Vanguard Group Inc Ventyx Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,162,272 shares of VTYX stock, worth $9.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,162,272

Previous 3,513,199 9.99%

Holding current value

$9.58 Million

Previous $4.04 Million 67.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$0.84 - $2.65 $294,778 - $929,956	-350,927 Reduced 9.99%	3,162,272 $6.77 Million
Q1 2025 May 09, 2025	BUY	$1.15 - $2.52 $5,878 - $12,882	5,112 Added 0.15%	3,513,199 $4.04 Million
Q4 2024 Feb 11, 2025	BUY	$1.72 - $3.12 $69,429 - $125,941	40,366 Added 1.16%	3,508,087 $7.68 Million
Q3 2024 Nov 13, 2024	BUY	$1.85 - $3.2 $875,936 - $1.52 Million	473,479 Added 15.81%	3,467,721 $7.56 Million
Q2 2024 Aug 13, 2024	SELL	$2.31 - $5.59 $1.64 Million - $3.98 Million	-711,230 Reduced 19.19%	2,994,242 $6.92 Million
Q1 2024 May 10, 2024	SELL	$1.9 - $10.13 $69,260 - $369,268	-36,453 Reduced 0.97%	3,705,472 $20.4 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $31.18 $2.24 Million - $33.7 Million	1,079,254 Added 40.53%	3,741,925 $9.24 Million
Q3 2023 Nov 14, 2023	BUY	$29.8 - $40.3 $8.28 Million - $11.2 Million	277,906 Added 11.65%	2,662,671 $92.5 Million
Q2 2023 Aug 14, 2023	BUY	$28.53 - $39.55 $16.5 Million - $22.8 Million	577,060 Added 31.92%	2,384,765 $78.2 Million
Q1 2023 May 15, 2023	BUY	$29.51 - $46.65 $9.19 Million - $14.5 Million	311,534 Added 20.82%	1,807,705 $60.6 Million
Q4 2022 Feb 10, 2023	BUY	$24.16 - $36.38 $9.48 Million - $14.3 Million	392,218 Added 35.53%	1,496,171 $49.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $2.49 Million - $7.62 Million	197,014 Added 21.72%	1,103,953 $38.5 Million
Q2 2022 Aug 12, 2022	BUY	$11.95 - $18.75 $5.14 Million - $8.06 Million	430,077 Added 90.19%	906,939 $11.1 Million
Q1 2022 May 13, 2022	SELL	$10.0 - $19.98 $910 - $1,818	-91 Reduced 0.02%	476,862 $6.47 Million
Q4 2021 Feb 14, 2022	BUY	$14.2 - $23.07 $6.77 Million - $11 Million	476,953 New	476,953 $9.47 Million

Others Institutions Holding VTYX

# of Institutions

122

Shares Held

49.4M

Call Options Held

70.4K

Put Options Held

51.4K

View Full List

About Ventyx Biosciences, Inc.

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $171M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

More about VTYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ventyx Biosciences, Inc. Transaction History